LT2768942T - Pristatymas į ląstelės vidų - Google Patents

Pristatymas į ląstelės vidų

Info

Publication number
LT2768942T
LT2768942T LTEP12841329.1T LT12841329T LT2768942T LT 2768942 T LT2768942 T LT 2768942T LT 12841329 T LT12841329 T LT 12841329T LT 2768942 T LT2768942 T LT 2768942T
Authority
LT
Lithuania
Prior art keywords
delivery
cell
Prior art date
Application number
LTEP12841329.1T
Other languages
English (en)
Inventor
Armon Sharei
Andrea Adamo
Robert Langer
Klavs Jensen
Original Assignee
Massachusetts Institute Of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute Of Technology filed Critical Massachusetts Institute Of Technology
Publication of LT2768942T publication Critical patent/LT2768942T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00Apparatus for enzymology or microbiology
    • C12M1/02Apparatus for enzymology or microbiology with agitation means; with heat exchange means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/02Form or structure of the vessel
    • C12M23/16Microfluidic devices; Capillary tubes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/02Electrical or electromagnetic means, e.g. for electroporation or for cell fusion
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/04Mechanical means, e.g. sonic waves, stretching forces, pressure or shear stimuli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Sustainable Development (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Clinical Laboratory Science (AREA)
  • Mechanical Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Electromagnetism (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Saccharide Compounds (AREA)
LTEP12841329.1T 2011-10-17 2012-10-17 Pristatymas į ląstelės vidų LT2768942T (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161548013P 2011-10-17 2011-10-17
US201261684301P 2012-08-17 2012-08-17
PCT/US2012/060646 WO2013059343A1 (en) 2011-10-17 2012-10-17 Intracellular delivery

Publications (1)

Publication Number Publication Date
LT2768942T true LT2768942T (lt) 2020-04-10

Family

ID=48141314

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP12841329.1T LT2768942T (lt) 2011-10-17 2012-10-17 Pristatymas į ląstelės vidų

Country Status (19)

Country Link
US (3) US10696944B2 (lt)
EP (2) EP3608394A1 (lt)
JP (2) JP6219832B2 (lt)
KR (1) KR102058568B1 (lt)
CN (3) CN107058101B (lt)
AU (1) AU2012326203B2 (lt)
BR (1) BR112014009346B1 (lt)
CA (1) CA2852672C (lt)
DK (1) DK2768942T3 (lt)
ES (1) ES2764105T3 (lt)
HR (1) HRP20200051T1 (lt)
HU (1) HUE047507T2 (lt)
LT (1) LT2768942T (lt)
PL (1) PL2768942T3 (lt)
PT (1) PT2768942T (lt)
RS (1) RS59898B1 (lt)
RU (1) RU2656156C2 (lt)
SI (1) SI2768942T1 (lt)
WO (1) WO2013059343A1 (lt)

Families Citing this family (191)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2656156C2 (ru) * 2011-10-17 2018-05-31 Массачусетс Инститьют Оф Текнолоджи Внутриклеточная доставка
US11046596B2 (en) 2012-10-25 2021-06-29 Hydrus Technology Pty. Ltd. Electrochemical liquid treatment apparatus
US9725709B2 (en) * 2013-03-12 2017-08-08 OpenCell Technologies, Inc. Intracellular delivery and transfection methods and devices
GB201308946D0 (en) 2013-05-16 2013-07-03 The Technology Partnership Plc Method and device
ITPD20130220A1 (it) * 2013-08-02 2015-02-03 Univ Padova Metodo per la riprogrammazione e programmazione cellulare mediante l'impiego di tecnologia microfluidica
KR102304167B1 (ko) * 2013-08-16 2021-09-24 메사추세츠 인스티튜트 오브 테크놀로지 세포로의 선택적 물질 전달
EP3071515A2 (en) 2013-11-18 2016-09-28 Rubius Therapeutics, Inc. Synthetic membrane-receiver complexes
HUE054471T2 (hu) 2014-04-01 2021-09-28 Rubius Therapeutics Inc Immunmodulációs módszerek és készítmények
CN106660836B (zh) 2014-05-23 2020-12-15 海卓斯科技有限公司 电化学处理方法
US11046595B2 (en) 2014-05-23 2021-06-29 Hydrus Technology Pty. Ltd. Electrochemical treatment methods
EP3164482B1 (en) 2014-07-03 2024-05-22 Massachusetts Institute of Technology Apparatus and method for optimization of cell electroporation
US10760040B1 (en) 2014-07-03 2020-09-01 NanoCav, LLC Mechanical transfection devices and methods
US10081816B1 (en) 2014-07-03 2018-09-25 Nant Holdings Ip, Llc Mechanical transfection devices and methods
RU2739794C2 (ru) 2014-10-31 2020-12-28 Массачусетс Инститьют Оф Текнолоджи Доставка биомолекул в клетки иммунной системы
US10526573B2 (en) 2014-11-14 2020-01-07 Massachusetts Institute Of Technology Disruption and field enabled delivery of compounds and compositions into cells
EP3037517A1 (en) * 2014-12-28 2016-06-29 Femtofab Co., Ltd. Process for modifying a cell by putting material into the cell
KR102428464B1 (ko) * 2014-12-28 2022-08-03 주식회사 펨토바이오메드 세포에 물질을 주입하여 세포를 변환시키는 방법
EP3037518B1 (en) * 2014-12-28 2020-05-06 Femtobiomed Inc. Device for putting material into cell
EP3037515A1 (en) * 2014-12-28 2016-06-29 Femtofab Co., Ltd. Modified cell prepared by putting material into the cell without using delivery vehicle
WO2016109864A1 (en) * 2015-01-07 2016-07-14 Indee. Inc. A method for mechanical and hydrodynamic microfluidic transfection and apparatus therefor
US11125739B2 (en) 2015-01-12 2021-09-21 Massachusetts Institute Of Technology Gene editing through microfluidic delivery
JP6886404B2 (ja) * 2015-01-30 2021-06-16 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California 初代造血細胞におけるタンパク質送達
WO2016168680A1 (en) * 2015-04-17 2016-10-20 Exocyte Therapeutics Pte Ltd. Method for developing exosome-based vaccines
JP6925984B2 (ja) * 2015-07-09 2021-08-25 マサチューセッツ インスティテュート オブ テクノロジー 無核細胞への物質の送達
DK3325080T3 (da) * 2015-07-24 2021-10-04 Sorrento Therapeutics Inc Fremgangsmåder til bedre indgivelse af aktive midler til tumorer
JP6929829B2 (ja) * 2015-07-24 2021-09-01 ソレント・セラピューティクス・インコーポレイテッド 薬剤送達装置
CN105384825B (zh) 2015-08-11 2018-06-01 南京传奇生物科技有限公司 一种基于单域抗体的双特异性嵌合抗原受体及其应用
JP7370529B2 (ja) * 2015-08-31 2023-10-30 剛士 田邊 多能性幹細胞製造システム、幹細胞の誘導方法、幹細胞の浮遊培養方法、幹細胞の浮遊培養器、人工多能性幹細胞の作製方法、及び動物細胞から特定の体細胞を作製する方法
US11613759B2 (en) 2015-09-04 2023-03-28 Sqz Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall
PL3344747T3 (pl) 2015-09-04 2023-06-19 Sqz Biotechnologies Company Wewnątrzkomórkowe dostarczanie biocząsteczek za pośrednictwem powierzchni z porami
US20180327706A1 (en) * 2015-10-19 2018-11-15 The Methodist Hospital Crispr-cas9 delivery to hard-to-transfect cells via membrane deformation
SG11201805217XA (en) 2015-12-28 2018-07-30 Novartis Ag Compositions and methods for the treatment of hemoglobinopathies
US20190017072A1 (en) * 2016-01-12 2019-01-17 Sqz Biotechnologies Company Intracellular delivery of complexes
JP7208010B2 (ja) 2016-03-29 2023-01-18 ユニバーシティ オブ サザン カリフォルニア 癌を標的とするキメラ抗原受容体
WO2017173373A1 (en) 2016-03-31 2017-10-05 Massachusetts Institute Of Technology Flow-through microfluidic methods and devices featuring membrane-perturbing surface interactions for intracellular delivery
EP3440186A4 (en) 2016-04-04 2019-12-11 Cytequest, Inc. SYSTEM, APPARATUS AND METHOD FOR THE ELECTROPORATION OF CELLS
US10717083B2 (en) 2016-04-11 2020-07-21 Indian Institute Of Technology, Bombay Microdevice for separating plasma from human blood
RU2747878C2 (ru) * 2016-05-03 2021-05-17 ЭсКьюЗед БАЙОТЕКНОЛОДЖИЗ КОМПАНИ Внутриклеточная доставка биомолекул для индукции толерантности
JP7602702B2 (ja) * 2016-05-03 2024-12-19 ステムセル テクノロジーズ カナダ インコーポレーテッド 寛容性を誘導するための生体分子の細胞内送達
WO2017201378A1 (en) * 2016-05-19 2017-11-23 University Of Rochester Micro-slits for reticulocyte maturation
US20190136224A1 (en) * 2016-05-31 2019-05-09 Massachusetts Institute Of Technology Hydrodynamically Controlled Electric Fields for High Throughput Transformation & High Throughput Parallel Transformation Platform
CA3026485A1 (en) 2016-06-06 2017-12-14 The Charles Stark Draper Laboratory, Inc. Systems and methods for cell transduction
US11999931B2 (en) 2016-08-20 2024-06-04 The Regents Of The University Of California High-throughput system and method for the temporary permeabilization of cells
WO2018047149A1 (en) * 2016-09-12 2018-03-15 Texas Children's Hospital Cell filtration as a means of introducing exogenous material into a cell
EP3516068B1 (en) 2016-09-19 2025-04-23 University of Southern California Non-radioactive cytotoxicity assays
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
SG10201913334RA (en) * 2016-10-21 2020-03-30 Agency Science Tech & Res Device, system and method for intracellular delivery of substances
EP3538269A4 (en) * 2016-11-08 2020-07-01 Georgia Tech Research Corporation METHODS OF INTRACELLULAR CONVECTION ADMINISTRATION
US10011848B2 (en) 2016-11-09 2018-07-03 City University Of Hong Kong System and method for delivery of substance into mammalian cells
US11332713B2 (en) 2016-11-16 2022-05-17 KSQ Therapeutics, Inc. Gene-regulating compositions and methods for improved immunotherapy
CN106525273B (zh) * 2016-11-24 2018-10-30 哈尔滨工业大学 基于量子点薄膜的细胞温度传感器及其制备方法
WO2018102795A2 (en) 2016-12-02 2018-06-07 University Of Southern California Synthetic immune receptors and methods of use thereof
TW201839136A (zh) 2017-02-06 2018-11-01 瑞士商諾華公司 治療血色素異常症之組合物及方法
GB201701946D0 (en) * 2017-02-06 2017-03-22 Univ Leeds Innovations Ltd Fluid flow device
CA3088495A1 (en) 2017-02-13 2018-08-16 The Regents Of The University Of California Device and method for intracellular delivery of biomolecular cargo via acoustic wave exposure
KR20200043369A (ko) * 2017-06-16 2020-04-27 님 싸이언티픽 인코포레이티드 나노 니들 및 관련된 기기 및 방법
US11801364B2 (en) * 2017-06-30 2023-10-31 Avectas Limited Electrospray catheter
US12570711B2 (en) 2017-09-27 2026-03-10 Angeles Therapeutics, Inc. Platforms for co-stimulation, novel car designs and other enhancements for adoptive cellular therapy
JP7057423B2 (ja) 2017-10-26 2022-04-19 レプリゲン・コーポレイション 微小交互接線流灌流フィルタ、処理容器およびその使用方法
US20190175506A1 (en) 2017-11-17 2019-06-13 Codiak Biosciences, Inc. Loading of Extracellular Vesicles through Imparting of Mechanical Shear
CN111601883B (zh) 2017-11-17 2024-06-21 艾欧凡斯生物治疗公司 由细针抽吸物和小活检物扩增til
JP2021503885A (ja) 2017-11-22 2021-02-15 アイオバンス バイオセラピューティクス,インコーポレイテッド 末梢血からの末梢血リンパ球(pbl)の拡大培養
EP3720878A1 (en) 2017-12-05 2020-10-14 SQZ Biotechnologies Company Intracellular delivery of biomolecules to modulate antibody production
WO2019126146A1 (en) 2017-12-19 2019-06-27 Xcell Biosciences, Inc. Methods of modulating cell phenotype by way of regulating the gaseous environment
IL320767A (en) * 2017-12-20 2025-07-01 Stemcell Technologies Canada Inc System for delivery of a payload into a cell
US11713446B2 (en) 2018-01-08 2023-08-01 Iovance Biotherapeutics, Inc. Processes for generating TIL products enriched for tumor antigen-specific T-cells
US12104172B2 (en) 2018-01-08 2024-10-01 Iovance Biotherapeutics, Inc. Processes for generating TIL products enriched for tumor antigen-specific t-cells
WO2019136459A1 (en) 2018-01-08 2019-07-11 Iovance Biotherapeutics, Inc. Processes for generating til products enriched for tumor antigen-specific t-cells
WO2019148184A2 (en) 2018-01-29 2019-08-01 The Regents Of The University Of California Guided magnetic nanostructures for targeted and high-throughput intracellular delivery
EP3755144A4 (en) 2018-02-21 2021-12-01 Nemametrix Inc. PLATFORM FOR THE PHENOTYPING OF TRANSGENIC ANIMALS AND USES THEREOF
EP3765068A2 (en) 2018-03-12 2021-01-20 SQZ Biotechnologies Company Intracellular delivery of biomolecules to modify immune response
CA3093826A1 (en) 2018-03-12 2019-09-19 Sqz Biotechnologies Company Methods for treating hpv-associated diseases
JP2019154314A (ja) * 2018-03-13 2019-09-19 国立大学法人九州大学 キャピラリーチップ及びこれを備える装置、並びに細胞への外来物質の導入方法
AU2019236204B2 (en) 2018-03-15 2026-02-26 KSQ Therapeutics, Inc. Gene-regulating compositions and methods for improved immunotherapy
JP2021518160A (ja) 2018-03-15 2021-08-02 ケーエスキュー セラピューティクス, インコーポレイテッド 免疫療法の改善のための遺伝子調節組成物及び遺伝子調節方法
WO2019195620A1 (en) * 2018-04-04 2019-10-10 The General Hospital Corporation Microfluidic systems and methods to denude mammalian oocytes
EP3556845A1 (en) 2018-04-20 2019-10-23 Cellix Limited A method and device for transfecting cells
CA3100050A1 (en) 2018-05-11 2019-11-14 Lupagen, Inc. Systems and methods for closed loop, real-time modifications of patient cells
SG11202011837UA (en) 2018-06-01 2020-12-30 Univ Southern California Diverse antigen binding domains, novel platforms and other enhancements for cellular therapy
WO2020005802A1 (en) * 2018-06-24 2020-01-02 University Of Oregon Microinjection chip, device, system and uses thereof for unicellular or multicellular organisms
US12440839B2 (en) 2018-08-21 2025-10-14 The Regents Of The University Of California High-throughput system and method for the temporary permeabilization of cells using lipid bilayers
CN112673022B (zh) 2018-09-10 2024-07-09 南京传奇生物科技有限公司 针对cd33的单结构域抗体及其构建体
CA3115245A1 (en) 2018-10-04 2020-04-09 Sqz Biotechnologies Company Intracellular delivery of biomolecules to enhance antigen presenting cell function
WO2020087074A2 (en) * 2018-10-26 2020-04-30 Kytopen Corporation Devices, systems, and kits for electroporation and methods of use thereof
CA3118493A1 (en) 2018-11-05 2020-05-14 Iovance Biotherapeutics, Inc. Expansion of tils utilizing akt pathway inhibitors
US20230039976A1 (en) 2018-11-05 2023-02-09 Iovance Biotherapeutics, Inc. Selection of improved tumor reactive t-cells
KR20210091213A (ko) 2018-11-05 2021-07-21 이오반스 바이오테라퓨틱스, 인크. 종양 침윤 림프구의 생성 방법 및 면역치료법에서 이의 용도
JP7688575B2 (ja) 2018-11-05 2025-06-04 アイオバンス バイオセラピューティクス,インコーポレイテッド 抗pd-1抗体に対して不応性のnsclc患者の治療
US10731012B2 (en) * 2018-11-06 2020-08-04 President And Fellows Of Harvard College Anti-clogging microfluidic multichannel device
KR102232757B1 (ko) * 2018-11-22 2021-03-26 (주)엑솔런스바이오테크놀로지 체외충격파를 이용한 표적물질 전달 장치
WO2020117856A1 (en) * 2018-12-04 2020-06-11 Cellfe, Inc. Methods and systems for intracellular delivery
US20220193131A1 (en) 2018-12-19 2022-06-23 Iovance Biotherapeutics, Inc. Methods of Expanding Tumor Infiltrating Lymphocytes Using Engineered Cytokine Receptor Pairs and Uses Thereof
EP3914722A1 (en) * 2019-01-25 2021-12-01 SQZ Biotechnologies Company Anucleate cell-derived vaccines
KR20210134353A (ko) 2019-02-28 2021-11-09 에스큐지 바이오테크놀로지스 컴퍼니 면역 반응을 변형시키기 위한 pbmc로의 생체분자의 전달
CN121360236A (zh) 2019-03-01 2026-01-20 阿奇洛伊斯生物制药公司 在抗原特异性免疫细胞中调节cd160功能的方法及其用途
US20220133795A1 (en) 2019-03-01 2022-05-05 Iovance Biotherapeutics, Inc. Expansion of Tumor Infiltrating Lymphocytes From Liquid Tumors and Therapeutic Uses Thereof
KR102354673B1 (ko) 2019-03-12 2022-01-25 고려대학교 산학협력단 관성을 기반으로 한 세포 내 전달 미세 유체 플랫폼
US20220177819A1 (en) 2019-03-12 2022-06-09 MxT Biotech Microfluidic system for intracellular delivery of materials and method therefor
CN113631575A (zh) 2019-03-15 2021-11-09 笛卡尔疗法股份有限公司 抗bcma嵌合抗原受体
EP3953039B1 (en) * 2019-04-08 2025-09-10 Stemcell Technologies Canada Inc. Cartridge for use in a system for delivery of a payload into a cell
WO2020207456A1 (en) * 2019-04-11 2020-10-15 The Chinese University Of Hong Kong Systems and methods for controlled membrane disruption
WO2020232029A1 (en) 2019-05-13 2020-11-19 Iovance Biotherapeutics, Inc. Methods and compositions for selecting tumor infiltrating lymphocytes and uses of the same in immunotherapy
US20220213422A1 (en) * 2019-05-15 2022-07-07 Cellfe, Inc. Methods and systems for intracellular delivery and products thereof
US12473522B2 (en) 2019-06-12 2025-11-18 Cellfe, Inc. Methods and systems for cell labeling and imaging
MX2021014861A (es) 2019-06-25 2022-06-22 Inari Agriculture Tech Inc Edicion genomica de reparacion dependiente de homologia mejorada.
CN110272810A (zh) * 2019-07-01 2019-09-24 广州世赛生物科技有限公司 外源物质递送至真核细胞内的装置和方法及其应用
AU2020299541A1 (en) * 2019-07-02 2022-01-27 Kytopen Corporation Devices, systems, and kits for electro-mechanical delivery and methods of use thereof
US11746354B2 (en) 2019-07-19 2023-09-05 Inari Agriculture Technology, Inc. Homology dependent repair genome editing
EP4056270A4 (en) * 2019-11-06 2024-04-10 Korea University Research and Business Foundation DROPLET DEFORMATION-BASED METHOD FOR TRANSFER OF MATERIAL INTO CELLS, AND ASSOCIATED CHIP
KR102483442B1 (ko) 2019-11-06 2022-12-30 고려대학교 산학협력단 액적 기반 미세유체 세포내 물질전달 방법 및 플랫폼
KR102499546B1 (ko) * 2020-10-07 2023-02-14 고려대학교 산학협력단 액적 변형에 기반한 세포내 물질 전달방법 및 이를 위한 칩
JP7749561B2 (ja) 2019-12-11 2025-10-06 アイオバンス バイオセラピューティクス,インコーポレイテッド 腫瘍浸潤リンパ球(til)の産生のためのプロセス及びそれを使用する方法
WO2021123920A1 (en) 2019-12-18 2021-06-24 Novartis Ag Compositions and methods for the treatment of hemoglobinopathies
KR20220169488A (ko) 2020-03-16 2022-12-27 유니버시티 오브 써던 캘리포니아 신규한 항원 결합 도메인 및 이를 포함하는 합성 항원 수용체
CN115516101A (zh) * 2020-03-26 2022-12-23 新加坡科技研究局 将一种或多种外源物质引入免疫细胞的方法和系统
WO2021194497A1 (en) * 2020-03-26 2021-09-30 Hewlett-Packard Development Company, L.P. Cell preparation with a series of detection devices
CA3176826A1 (en) 2020-05-04 2021-11-11 Iovance Biotherapeutics, Inc. Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
TW202208616A (zh) 2020-05-04 2022-03-01 美商艾歐凡斯生物治療公司 改良之腫瘤反應性t細胞的選擇
KR20230035235A (ko) * 2020-05-05 2023-03-13 3디 시스템즈 인코오퍼레이티드 마이크로코즘 바이오 스캐폴드 및 그 적용
US20230181712A1 (en) 2020-05-11 2023-06-15 Hoffmann-La Roche Inc. Combination therapy with modified pbmcs and an immunoconjugate
CN116134125A (zh) * 2020-05-22 2023-05-16 Sqz生物技术公司 用于自动处理细胞的即时医疗系统
CN116348583A (zh) * 2020-05-26 2023-06-27 川赛托斯有限责任公司 用于转染的装置和方法
WO2022026621A1 (en) 2020-07-29 2022-02-03 Sqz Biotechnologies Company Methods to stimulate immune responses to mutant ras using anucleate cells
EP4188428A1 (en) 2020-07-29 2023-06-07 SQZ Biotechnologies Company Methods to stimulate immune responses to mutant ras using nucleated cells
CN112268934B (zh) * 2020-09-16 2022-06-28 东南大学 一种针对循环肿瘤细胞的检测芯片及其检测方法
WO2022076606A1 (en) 2020-10-06 2022-04-14 Iovance Biotherapeutics, Inc. Treatment of nsclc patients with tumor infiltrating lymphocyte therapies
US20230372397A1 (en) 2020-10-06 2023-11-23 Iovance Biotherapeutics, Inc. Treatment of nsclc patients with tumor infiltrating lymphocyte therapies
CN112275337B (zh) * 2020-10-29 2022-03-18 上海荧辉医疗器械有限公司 一种微流控芯片及细胞筛选装置和方法
JP7642813B2 (ja) 2020-11-18 2025-03-10 セルフィー、インク. 生体細胞へのメカノポレーションベースのペイロード送達のための方法及びシステム
WO2022125941A1 (en) 2020-12-11 2022-06-16 Iovance Biotherapeutics, Inc. Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with braf inhibitors and/or mek inhibitors
WO2022133149A1 (en) 2020-12-17 2022-06-23 Iovance Biotherapeutics, Inc. Treatment of cancers with tumor infiltrating lymphocytes
WO2022133140A1 (en) 2020-12-17 2022-06-23 Iovance Biotherapeutics, Inc. Treatment with tumor infiltrating lymphocyte therapies in combination with ctla-4 and pd-1 inhibitors
US12227729B2 (en) 2020-12-24 2025-02-18 Cellfe, Inc. Methods and systems for high-throughput cell processing
JP2024503278A (ja) 2020-12-29 2024-01-25 スクイーズ バイオテクノロジーズ カンパニー 修飾pbmcを用いたがんの治療方法
US12018240B2 (en) * 2020-12-29 2024-06-25 Stemcell Technologies Canada Inc. High-throughput microfluidic chip having parallelized constrictions for perturbing cell membranes
JP2024503277A (ja) 2020-12-29 2024-01-25 スクイーズ バイオテクノロジーズ カンパニー 活性化抗原担体の製剤
JP2024503279A (ja) 2020-12-29 2024-01-25 スクイーズ バイオテクノロジーズ カンパニー Pbmcの凍結保存のための製剤
EP4271793A1 (en) 2020-12-29 2023-11-08 SQZ Biotechnologies Company Microfluidic chip having increased throughput for use in a system for delivery of a payload into a cell
EP4271408A1 (en) 2020-12-29 2023-11-08 SQZ Biotechnologies Company Methods for treating cancers with activating antigen carriers
EP4277981A1 (en) * 2021-01-13 2023-11-22 The General Hospital Corporation Viscoelastic mechanoporation systems and methods of use thereof
TW202241508A (zh) 2021-01-29 2022-11-01 美商艾歐凡斯生物治療公司 細胞介素相關之腫瘤浸潤性淋巴球組合物及方法
KR20240032711A (ko) 2021-03-25 2024-03-12 이오반스 바이오테라퓨틱스, 인크. T-세포 공배양 효능 검정 및 세포 치료제와 함께 사용하기 위한 방법 및 조성물
WO2022207717A1 (en) 2021-04-01 2022-10-06 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Multistage device and method for intracellular delivery
WO2022212955A1 (en) 2021-04-02 2022-10-06 Sqz Biotechnologies Company Reprogramming of cells and uses thereof
WO2022220539A1 (ko) 2021-04-12 2022-10-20 ㈜엠엑스티바이오텍 세포 내 물질 전달 플랫폼
JP2024515189A (ja) 2021-04-19 2024-04-05 アイオバンス バイオセラピューティクス,インコーポレイテッド 細胞免疫療法におけるキメラ共刺激受容体、ケモカイン受容体、及びそれらの使用
EP4337769A1 (en) 2021-05-10 2024-03-20 SQZ Biotechnologies Company Methods for delivering genome editing molecules to the nucleus or cytosol of a cell and uses thereof
EP4359527A2 (en) 2021-06-23 2024-05-01 Novartis AG Compositions and methods for the treatment of hemoglobinopathies
CA3226111A1 (en) 2021-07-22 2023-01-26 Iovance Biotherapeutics, Inc. Method for cryopreservation of solid tumor fragments
EP4377446A1 (en) 2021-07-28 2024-06-05 Iovance Biotherapeutics, Inc. Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with kras inhibitors
WO2023010090A1 (en) 2021-07-29 2023-02-02 Sqz Biotechnologies Company Methods to generate enhanced tumor infiltrating lymphocytes through microfluidic delivery
CN113862112B (zh) * 2021-09-03 2023-08-15 南昌大学 微流控离心式挤压的细胞转染系统及细胞转染方法
US20230130686A1 (en) * 2021-10-25 2023-04-27 Massachusetts Institute Of Technology Devices and systems for delivery of materials to cells
AR127482A1 (es) 2021-10-27 2024-01-31 Iovance Biotherapeutics Inc Sistemas y métodos para coordinar la fabricación de células para inmunoterapia específica de paciente
CA3237410A1 (en) 2021-11-10 2023-05-19 Friedrich Graf Finck VON FINCKENSTEIN Methods of expansion treatment utilizing cd8 tumor infiltrating lymphocytes
WO2023087009A1 (en) 2021-11-11 2023-05-19 Sqz Biotechnologies Company Methods to generate enhanced tumor infiltrating lymphocytes through microfluidic delivery
CN114181825B (zh) * 2021-11-29 2024-05-03 南昌大学 一种外加电场作用下微流控离心式挤压的细胞转染系统
DE102021214276A1 (de) * 2021-12-14 2023-06-15 Robert Bosch Gesellschaft mit beschränkter Haftung Vorrichtung und Verfahren zum Splitten dreidimensionaler Agglomerate
EP4460370A1 (en) 2022-01-05 2024-11-13 Stemcell Technologies Canada Inc. Modified hematopoietic stem cells and uses thereof
CN114316950B (zh) * 2022-01-12 2022-08-26 广东粤港澳大湾区国家纳米科技创新研究院 通过前体胶囊制备量子点材料的方法和量子点材料、量子点组合物以及量子点器件
CA3243416A1 (en) 2022-01-28 2023-08-03 Iovance Biotherapeutics, Inc. TUMOR INFILTRATION LYMPHOCYTES MODIFIED TO EXPRESS PAYLOADS
US20250099588A1 (en) 2022-01-28 2025-03-27 Iovance Biotherapeutics, Inc. Cytokine associated tumor infiltrating lymphocytes compositions and methods
WO2023164466A1 (en) 2022-02-23 2023-08-31 Sqz Biotechnologies Company Methods of producing glial cells and uses thereof
CA3247638A1 (en) 2022-04-06 2023-10-12 Maria Fardis TREATMENT OF PATIENTS WITH NON-SMALL CELL LUNG CARCINOMA (NSCLC) WITH TUMOR-INFILTRATING LYMPHOCYTE THERAPIES
CA3248034A1 (en) 2022-04-15 2023-10-19 Iovance Biotherapeutics, Inc. METHODS FOR EXPANSION OF TIL CELLS BY MEANS OF SPECIFIC CYTOKINE COMBINATIONS AND/OR AKT INHIBITOR TREATMENT
CA3251533A1 (en) 2022-05-10 2023-11-16 Iovance Biotherapeutics, Inc. TREATMENT OF CANCER PATIENTS WITH TUMOR-INFILTRATING LYMPHOCYTE THERAPIES IN COMBINATION WITH AN IL-15R AGONIST
JP2025522291A (ja) 2022-05-24 2025-07-15 ステムセル テクノロジーズ カナダ インコーポレイテッド 自己増幅rnaを用いた細胞の再プログラミング
JP2025517524A (ja) 2022-05-27 2025-06-05 ステムセル テクノロジーズ カナダ インコーポレイテッド 細胞内にペイロードを送達するためのシステムで使用するカートリッジ及びデバイス
EP4299739A1 (en) 2022-06-30 2024-01-03 Inari Agriculture Technology, Inc. Compositions, systems, and methods for genome editing
WO2024005864A1 (en) 2022-06-30 2024-01-04 Inari Agriculture Technology, Inc. Compositions, systems, and methods for genome editing
WO2024005863A1 (en) 2022-06-30 2024-01-04 Inari Agriculture Technology, Inc. Compositions, systems, and methods for genome editing
EP4299733A1 (en) 2022-06-30 2024-01-03 Inari Agriculture Technology, Inc. Compositions, systems, and methods for genome editing
CN119894529A (zh) 2022-07-28 2025-04-25 加拿大干细胞技术公司 使用增强型抗原呈递细胞治疗癌症的方法
EP4561602A1 (en) 2022-07-28 2025-06-04 Stemcell Technologies Canada Inc. Polynucleotides encoding linked antigens and uses thereof
WO2024026491A2 (en) 2022-07-28 2024-02-01 Sqz Biotechnologies Company Enhanced antigen presenting cell formulations
EP4565683A1 (en) 2022-08-01 2025-06-11 Iovance Biotherapeutics, Inc. Chimeric costimulatory receptors, chemokine receptors, and the use of same in cellular immunotherapies
WO2024068996A1 (en) 2022-09-30 2024-04-04 Centre Hospitalier Universitaire Vaudois (C.H.U.V.) Anti-sars-cov-2 antibodies and use thereof in the treatment of sars-cov-2 infection
WO2024098024A1 (en) 2022-11-04 2024-05-10 Iovance Biotherapeutics, Inc. Expansion of tumor infiltrating lymphocytes from liquid tumors and therapeutic uses thereof
KR20250122544A (ko) 2022-11-21 2025-08-13 이오반스 바이오테라퓨틱스, 인크. 종양 침윤 림프구의 확장을 위한 2차원 공정 및 이를 통한 요법
WO2024118836A1 (en) 2022-11-30 2024-06-06 Iovance Biotherapeutics, Inc. Processes for production of tumor infiltrating lymphocytes with shortened rep step
WO2024178397A2 (en) 2023-02-24 2024-08-29 Elevatebio Technologies, Inc. Modified immune effector cells and methods of use
WO2024218295A1 (en) 2023-04-21 2024-10-24 Vib Vzw Allelic combinations in crops for yield increase
KR20260018078A (ko) 2023-05-25 2026-02-06 디스패치 바이오테라퓨틱스, 인크. 암을 치료하기 위한 표적으로서의 합성 암 항원
CN121712794A (zh) 2023-06-29 2026-03-20 迪斯派奇生物治疗公司 合成细胞因子受体
WO2025076141A1 (en) 2023-10-03 2025-04-10 Inari Agriculture Technology, Inc. Viral delivery of grna to the scion
WO2025101484A1 (en) 2023-11-06 2025-05-15 Iovance Biotherapeutics, Inc. Treatment of endometrial cancers with tumor infiltrating lymphocyte therapies
WO2025168705A1 (en) 2024-02-08 2025-08-14 Vib Vzw Means and methods for the production of saponins with endosomal escape-enhancing properties
WO2025171383A2 (en) 2024-02-09 2025-08-14 Dispatch Biotherapeutics, Inc. Engineered cancer antigens and related methods and uses
WO2025171388A1 (en) 2024-02-09 2025-08-14 Dispatch Biotherapeutics, Inc. Engineered cancer antigens with modified domains and related methods and uses
WO2025240518A1 (en) 2024-05-14 2025-11-20 Dispatch Biotherapeutics, Inc. Modified lentiviral transfer plasmids
WO2026006767A1 (en) 2024-06-28 2026-01-02 Dispatch Biotherapeutics, Inc. Tethered il-9/il-9r and related engineered cells and methods

Family Cites Families (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2502621C3 (de) * 1975-01-23 1978-09-14 Kernforschungsanlage Juelich Gmbh, 5170 Juelich Messung elastischer und dielektrischer Eigenschaften der Membran lebender Zellen
US4478824A (en) 1983-08-08 1984-10-23 Franco Robert S Method for altering red blood cell function and survival
FR2569477B1 (fr) 1984-08-24 1987-01-02 Descartes Universite Rene Appareil et procede pour la determination de la deformabilite des globules rouges du sang
JP2720161B2 (ja) 1988-02-01 1998-02-25 株式会社アドバンス 細胞変形能測定装置
JP2685544B2 (ja) 1988-11-11 1997-12-03 株式会社日立製作所 血液フィルタおよび血液検査方法並びに血液検査装置
JP2532707B2 (ja) 1990-03-08 1996-09-11 佑二 菊池 血液回路及びこれを用いた血液測定装置及び血液測定方法
HK1004060A1 (en) 1990-04-24 1998-11-13 Flustat Pty Ltd Oral vaccine comprising antigen surface-associated with red blood cells
US5658892A (en) 1993-01-15 1997-08-19 The General Hospital Corporation Compound delivery using high-pressure impulse transients
US6218166B1 (en) 1994-12-09 2001-04-17 John Wayne Cancer Institute Adjuvant incorporation into antigen carrying cells: compositions and methods
CA2214649C (en) 1995-03-08 2007-06-12 Zeling Cai Antigen presenting system and methods for activation of t-cells
US6051409A (en) 1995-09-25 2000-04-18 Novartis Finance Corporation Method for achieving integration of exogenous DNA delivered by non-biological means to plant cells
DE69626853T2 (de) 1995-12-04 2004-02-19 Puget Sound Blood Center And Programm, Seattle Nicht-immunogene Blutplättchen und rote Blutzellen enthaltende Zubereitungen
US5951976A (en) 1996-03-28 1999-09-14 Whitenead Institute For Biomedical Research Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
US5885470A (en) 1997-04-14 1999-03-23 Caliper Technologies Corporation Controlled fluid transport in microfabricated polymeric substrates
DE69732225T2 (de) 1997-05-05 2005-06-23 Dideco S.R.L., Mirandola Verfahren zur Verkapselung von biologisch aktiven Stoffen in Erythrocyten und Gerät dafür
US5842787A (en) 1997-10-09 1998-12-01 Caliper Technologies Corporation Microfluidic systems incorporating varied channel dimensions
WO2003046170A1 (en) 2001-11-27 2003-06-05 Cellectricon Ab A method for combined parallel agent delivery and electroporation for cell structures and use thereof
SE9704076D0 (sv) 1997-11-06 1997-11-06 Holdingbolaget Vid Goeteborgs Method for permeabilisation of cell structures and use thereof
GB9816583D0 (en) 1998-07-31 1998-09-30 Univ Ulster Nucleic acid carrier
AU5757100A (en) 1999-06-21 2001-01-09 General Hospital Corporation, The Methods and devices for cell culturing and organ assist systems
JP2002325572A (ja) 2000-12-25 2002-11-12 Univ Osaka 外来物質の導入方法
AU2002252073A1 (en) 2001-02-22 2002-09-12 The Scepens Eye Research Institute, Inc. Tolerogenic antigen presenting cells and in treating immune-inflammatory conditions
WO2003020039A1 (en) 2001-08-28 2003-03-13 Rush-Presbyterian-St. Luke's Medical Center Immune tolerance to predetermined antigens
US20030133922A1 (en) 2002-01-15 2003-07-17 Kasha John R. Oral tolerance using allogeneic platelets in ITP
WO2003104788A1 (ja) * 2002-06-05 2003-12-18 松下電器産業株式会社 細胞外電位測定デバイスおよびその製造方法
GB0214528D0 (en) 2002-06-24 2002-08-07 Univ Aberdeen Materials and methods for induction of immune tolerance
AU2004204456A1 (en) 2003-01-09 2004-07-29 Invitrogen Corporation Cellular delivery and activation polypeptide-nucleic acid complexes
US20060134067A1 (en) * 2003-02-18 2006-06-22 Maxcyte, Inc. Loading of cells with antigens by electroporation
JP4116057B2 (ja) * 2004-06-17 2008-07-09 研 中田 生体力学的刺激負荷装置
EP1771608B1 (en) 2004-07-27 2010-09-15 DSM IP Assets B.V. Process for making a carbon nanotubes/ultra-high molar mass polyethylene composite fibre
US20060134772A1 (en) * 2004-11-18 2006-06-22 The Regents Of The University Of California System for locating cells and for cellular analysis
WO2006095330A2 (en) 2005-03-10 2006-09-14 Yeda Research And Development Co. Ltd. Methods and immunogenic cell preparations for treating antigen-associated diseases
US7704743B2 (en) 2005-03-30 2010-04-27 Georgia Tech Research Corporation Electrosonic cell manipulation device and method of use thereof
US7993821B2 (en) 2005-08-11 2011-08-09 University Of Washington Methods and apparatus for the isolation and enrichment of circulating tumor cells
US9005974B2 (en) 2005-12-09 2015-04-14 Academish Medisch Centrum Bij De Universiteit Van Amsterdam Means and methods for influencing the stability of cells
WO2007097934A2 (en) 2006-02-17 2007-08-30 Elusys Therapeutics, Inc. Methods and compositions for using erythrocytes as carriers for delivery of drugs
US8293524B2 (en) * 2006-03-31 2012-10-23 Fluxion Biosciences Inc. Methods and apparatus for the manipulation of particle suspensions and testing thereof
US20070249038A1 (en) * 2006-04-21 2007-10-25 Andrea Adamo Microfluidic device for single cell targeted operations
CA2662826A1 (en) * 2006-08-17 2008-02-21 Massachusetts Institute Of Technology Method and apparatus for microfluidic injection
US20080311140A1 (en) 2007-05-29 2008-12-18 Baylor College Of Medicine Antigen specific immunosuppression by dendritic cell therapy
US8841135B2 (en) 2007-06-20 2014-09-23 University Of Washington Biochip for high-throughput screening of circulating tumor cells
JP4469959B2 (ja) 2007-06-21 2010-06-02 国立大学法人名古屋大学 細胞壁を備える細胞に外来物質を導入する方法
FR2919804B1 (fr) 2007-08-08 2010-08-27 Erytech Pharma Composition et vaccin therapeutique anti-tumoral
GB0718160D0 (en) 2007-09-18 2007-10-24 Medical Res Council Methods
EP2057998A1 (en) 2007-10-31 2009-05-13 Universitätsklinikum Hamburg-Eppendorf Use of modified cells for the treatment of multiple sclerosis
EP2216639A4 (en) * 2007-11-28 2014-01-15 Konica Minolta Opto Inc APPARATUS AND METHOD FOR MEASURING BLOOD FLUIDITY
US20090280518A1 (en) * 2008-05-12 2009-11-12 Massachusetts Institute Of Technology System for high throughput measurement of mechanical properties of cells
JP2010002582A (ja) 2008-06-19 2010-01-07 Konica Minolta Business Technologies Inc 画像形成装置
WO2010010513A2 (en) 2008-07-21 2010-01-28 Trium Investments (Pty) Limited Solar panel mounting arrangement
JP5137129B2 (ja) 2008-07-23 2013-02-06 国立大学法人山口大学 血液細胞の力学的特性測定装置
EP2321405A4 (en) 2008-08-08 2012-09-12 Agency Science Tech & Res Microfluidic continuous flow device
US8211656B2 (en) 2008-08-13 2012-07-03 The Invention Science Fund I, Llc Biological targeting compositions and methods of using the same
US20110091973A1 (en) 2008-12-09 2011-04-21 Glaser Larry F Modified and fusion enhanced erythrocytes, cells and uses thereof
US9157550B2 (en) 2009-01-05 2015-10-13 The Board Of Trustees Of The University Of Illinois Microfluidic systems and methods
US9017991B2 (en) 2009-03-13 2015-04-28 Tufts University Methods tip assemblies and kits for introducing material into cells
EP2405959A4 (en) 2009-03-13 2013-10-16 Univ Tufts METHODS, DEVICES AND KITS FOR INTRODUCING GENETIC MATERIAL IN LIVING CELLS
WO2010107399A1 (en) 2009-03-20 2010-09-23 Agency For Science, Technology And Research Devices for separating cells and methods of using them
WO2010129671A2 (en) 2009-05-08 2010-11-11 Chauncey Sayre Method of and apparatus for changing one type of cell into another type of cell
GB0909754D0 (en) 2009-06-05 2009-07-22 Magnani Mauro Drug delivery systems
WO2011005799A2 (en) 2009-07-06 2011-01-13 Novartis Ag Self replicating rna molecules and uses thereof
US9364831B2 (en) * 2009-08-08 2016-06-14 The Regents Of The University Of California Pulsed laser triggered high speed microfluidic switch and applications in fluorescent activated cell sorting
DK2493487T3 (en) 2009-10-27 2016-12-05 Erytech Pharma Composition for induction of specific immunological tolerance
CA2951341A1 (en) 2009-12-21 2011-06-30 Keygene N.V. Improved techniques for transfecting protoplasts
US9005579B2 (en) 2010-01-05 2015-04-14 Contrafect Corporation Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
US8844570B2 (en) 2010-02-01 2014-09-30 California Institute Of Technology Generating binary states using a microfluidic channel
JP5704590B2 (ja) 2010-02-05 2015-04-22 国立大学法人東京農工大学 サイズ選択マイクロキャビティアレイを用いた循環腫瘍細胞の検出
US20110287948A1 (en) 2010-03-22 2011-11-24 Massachusetts Institute Of Technology Measurement of material properties and related methods and compositions based on cytoadherence
WO2015061458A1 (en) 2013-10-22 2015-04-30 Cellanyx Diagnostics, Inc. Systems, devices and methods for microfluidic culturing, manipulation and analysis of tissues and cells
CA2825093A1 (en) 2011-01-19 2012-07-26 The University Of British Columbia Apparatus and method for particle separation
RU2612915C2 (ru) 2011-02-28 2017-03-13 Президент Энд Феллоуз Ов Харвард Колледж Система культивирования клеток
EP2714884B1 (en) 2011-05-27 2019-08-21 The University Of British Columbia Microfluidic cell trap and assay apparatus for high-throughput analysis
MX2013013243A (es) 2011-07-05 2014-05-30 Sotio As Medios y metodos para activar la inmunoterapia celular del cancer utilizando celulas cancerosas destruidas mediante presion hidrostatica y celulas dendriticas.
US20130065314A1 (en) 2011-08-25 2013-03-14 Phytocentric Biotech Inc. Algal transformation systems, compositions and methods
RU2656156C2 (ru) 2011-10-17 2018-05-31 Массачусетс Инститьют Оф Текнолоджи Внутриклеточная доставка
HK1209021A1 (en) 2012-06-07 2016-03-24 President And Fellows Of Harvard College Nanotherapeutics for drug targeting
US9255245B2 (en) 2012-07-03 2016-02-09 Agilent Technologies, Inc. Sample probes and methods for sampling intracellular material
CN102925337B (zh) 2012-11-08 2014-06-18 武汉友芝友生物制药有限公司 一种微流体细胞捕获芯片及其制备方法
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
GB201300049D0 (en) 2013-01-03 2013-02-20 Transimmune Ag Method for obtaining immuno-stimulatory dendritic cells
GB201300052D0 (en) 2013-01-03 2013-02-20 Transimmune Ag Method for obtaining immuno-suppressive dendritic cells
WO2014120956A1 (en) 2013-01-30 2014-08-07 Asta Fluidic Technologies, Inc. Microfluidic-based fetal red blood cell detection
US9725709B2 (en) 2013-03-12 2017-08-08 OpenCell Technologies, Inc. Intracellular delivery and transfection methods and devices
CN105452471A (zh) 2013-03-15 2016-03-30 加利福尼亚大学董事会 使用光热平台向活细胞中的高通量运输物递送
KR20140115560A (ko) 2013-03-21 2014-10-01 인하대학교 산학협력단 기계적 스트레스를 이용한 단세포 생물체 개질 방법 및 이에 사용되는 장치
EP3789487A1 (en) 2013-04-03 2021-03-10 Memorial Sloan Kettering Cancer Center Effective generation of tumor-targeted t-cells derived from pluripotent stem cells
KR102304167B1 (ko) 2013-08-16 2021-09-24 메사추세츠 인스티튜트 오브 테크놀로지 세포로의 선택적 물질 전달
US10137673B2 (en) 2013-12-31 2018-11-27 Canon U.S. Life Sciences, Inc. Methods and systems for continuous flow cell lysis in a microfluidic device
HUE054471T2 (hu) 2014-04-01 2021-09-28 Rubius Therapeutics Inc Immunmodulációs módszerek és készítmények
US20170175128A1 (en) 2014-04-18 2017-06-22 Editas Medicine, Inc. Crispr-cas-related methods, compositions and components for cancer immunotherapy
EP3164482B1 (en) 2014-07-03 2024-05-22 Massachusetts Institute of Technology Apparatus and method for optimization of cell electroporation
RU2739794C2 (ru) * 2014-10-31 2020-12-28 Массачусетс Инститьют Оф Текнолоджи Доставка биомолекул в клетки иммунной системы
US10526573B2 (en) 2014-11-14 2020-01-07 Massachusetts Institute Of Technology Disruption and field enabled delivery of compounds and compositions into cells
WO2016094715A2 (en) 2014-12-10 2016-06-16 Berkeley Lights, Inc. Movement and selection of micro-objects in a microfluidic apparatus
WO2016109864A1 (en) 2015-01-07 2016-07-14 Indee. Inc. A method for mechanical and hydrodynamic microfluidic transfection and apparatus therefor
US11125739B2 (en) 2015-01-12 2021-09-21 Massachusetts Institute Of Technology Gene editing through microfluidic delivery
WO2016183482A1 (en) 2015-05-13 2016-11-17 Rubius Therapeutics, Inc. Membrane-receiver complex therapeutics
GB201513278D0 (en) 2015-07-03 2015-09-09 Transimmune Ag And Yale University Device and method for obtaining immunostimulatory antigen-presenting cells
JP6925984B2 (ja) 2015-07-09 2021-08-25 マサチューセッツ インスティテュート オブ テクノロジー 無核細胞への物質の送達
US11613759B2 (en) 2015-09-04 2023-03-28 Sqz Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall
PL3344747T3 (pl) 2015-09-04 2023-06-19 Sqz Biotechnologies Company Wewnątrzkomórkowe dostarczanie biocząsteczek za pośrednictwem powierzchni z porami
KR20180102096A (ko) 2015-12-22 2018-09-14 생귀 바이오 피티와이. 엘티디 에리스로사이트를 사용한 치료 방법
MX2018008515A (es) 2016-01-11 2019-05-09 Rubius Therapeutics Inc Composiciones y metodos relacionados con sistemas celulares terapeuticos multimodales para indicaciones inmunitarias.
US20190017072A1 (en) 2016-01-12 2019-01-17 Sqz Biotechnologies Company Intracellular delivery of complexes
RU2747878C2 (ru) 2016-05-03 2021-05-17 ЭсКьюЗед БАЙОТЕКНОЛОДЖИЗ КОМПАНИ Внутриклеточная доставка биомолекул для индукции толерантности
JP7602702B2 (ja) 2016-05-03 2024-12-19 ステムセル テクノロジーズ カナダ インコーポレーテッド 寛容性を誘導するための生体分子の細胞内送達
US20170326213A1 (en) 2016-05-16 2017-11-16 Augusta University Research Institute, Inc. Protein-Coupled Red Blood Cell Compositions and Methods of Their Use
CN106244543A (zh) 2016-07-29 2016-12-21 北京时合生物科技有限公司 一种pbmc体外诱导分化成为树突状细胞的方法
EP3538269A4 (en) 2016-11-08 2020-07-01 Georgia Tech Research Corporation METHODS OF INTRACELLULAR CONVECTION ADMINISTRATION
US12440839B2 (en) * 2018-08-21 2025-10-14 The Regents Of The University Of California High-throughput system and method for the temporary permeabilization of cells using lipid bilayers
EP4056270A4 (en) * 2019-11-06 2024-04-10 Korea University Research and Business Foundation DROPLET DEFORMATION-BASED METHOD FOR TRANSFER OF MATERIAL INTO CELLS, AND ASSOCIATED CHIP
EP4277981A1 (en) * 2021-01-13 2023-11-22 The General Hospital Corporation Viscoelastic mechanoporation systems and methods of use thereof
WO2022207717A1 (en) * 2021-04-01 2022-10-06 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Multistage device and method for intracellular delivery
CN116964210A (zh) * 2021-04-12 2023-10-27 明新特生物科技公司 细胞内物质递送平台

Also Published As

Publication number Publication date
HRP20200051T1 (hr) 2020-03-20
EP2768942B1 (en) 2019-12-04
BR112014009346A2 (pt) 2017-04-18
EP2768942A4 (en) 2015-05-27
CN113337402A (zh) 2021-09-03
CA2852672A1 (en) 2013-04-25
DK2768942T3 (da) 2020-01-27
JP2018023395A (ja) 2018-02-15
HUE047507T2 (hu) 2020-04-28
CN113337402B (zh) 2024-11-29
AU2012326203A1 (en) 2014-05-15
US20190093073A1 (en) 2019-03-28
EP3608394A1 (en) 2020-02-12
JP6219832B2 (ja) 2017-10-25
RS59898B1 (sr) 2020-03-31
WO2013059343A1 (en) 2013-04-25
US20200277566A1 (en) 2020-09-03
US10696944B2 (en) 2020-06-30
SI2768942T1 (sl) 2020-03-31
AU2012326203A2 (en) 2014-05-22
JP2014533936A (ja) 2014-12-18
CN103987836A (zh) 2014-08-13
CA2852672C (en) 2021-07-20
CN107058101B (zh) 2021-06-01
PL2768942T3 (pl) 2020-05-18
RU2014119926A (ru) 2015-11-27
PT2768942T (pt) 2020-01-21
CN107058101A (zh) 2017-08-18
BR112014009346B1 (pt) 2020-09-15
ES2764105T3 (es) 2020-06-02
KR20140116374A (ko) 2014-10-02
CN103987836B (zh) 2018-04-10
US20140287509A1 (en) 2014-09-25
JP6629272B2 (ja) 2020-01-15
RU2656156C2 (ru) 2018-05-31
AU2012326203B2 (en) 2017-11-30
KR102058568B1 (ko) 2020-01-22
EP2768942A1 (en) 2014-08-27

Similar Documents

Publication Publication Date Title
LT2768942T (lt) Pristatymas į ląstelės vidų
BR112014002399A2 (pt) conjunto
EP2667915A4 (en) INJEKTOR
EP2688642A4 (en) neurostimulator
DK2775557T3 (da) Brændselscelle
EP2752667A4 (en) AUTO ANALYZER
EP2673344A4 (en) STABLE BIO OIL
EP2713945A4 (en) ÖSOPHAGEAL STENT
IL231616A0 (en) Tropicalizing agent
DK2731571T3 (da) Forbedringer vedrørende leveringsanordninger
BR112013015345A2 (pt) nacela
EP2700534A4 (en) Charging apparatus
EP2720045A4 (en) Autoanalyzer
EP2757623A4 (en) FUEL CELL
DK2681530T3 (da) Gennemstrømmelig målecelle
DE112011105455T8 (de) Brennstoffzelle
EP2768053A4 (en) FUEL CELL
EP2696415A4 (en) FUEL CELL
FR2978994B1 (fr) .
FI20116111L (fi) Mikromanipulaattorijärjestely
DK2500470T3 (da) Hoved-arbejdsvogn
DE112011102608T8 (de) Cetanzahl-Bestimmungsvorrrichtung
FR2976466B1 (fr) Etui range-piolet
EP2708238A4 (en) CYTOLYTIC CELL INDUCTION AGENT
ES2396651B2 (es) Material biosanitario antiulcera.